KODIAK SCIENCES INC. Temporary Equity, Liquidation Preference
KODIAK SCIENCES INC. (KOD) had Temporary Equity, Liquidation Preference of $0 as of 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2019-03-27
- 2018-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2018-09-30: Temporary Equity, Liquidation Preference $50.32M.
- 2017-12-31: Temporary Equity, Liquidation Preference $50.32M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-27 |
| 2018-09-30 | $50.32M 10-Q · filed 2018-11-16 |
| 2017-12-31 | $50.32M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |